Crescent Biopharma CBIO Balance Sheet (2013-2026)

NASDAQ CBIO
$16.23 -1.09 (-6.29%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
101.92M90.25M76.52M60.24M51.60M47.87M65.00M58.04M49.41M41.79M31.30M22.39M14.39M34.77M22.43M133.26M213.19M189.20M171.60M
Short-term Investments (Quarter)
Cash & Current Investments (Quarter)
101.92M90.25M76.52M60.24M51.60M47.87M65.00M58.04M49.41M41.79M31.30M22.39M14.39M34.77M22.43M133.26M213.19M189.20M171.60M
Receivables - Net (Quarter)
18.00M
Receivables - Other (Quarter)
0.00M0.00M0.00M0.12M0.09M0.14M0.23M0.22M0.19M0.18M0.11M0.08M0.05M0.14M0.08M
Receivables (Quarter)
0.14M18.00M
Prepaid Assets (Quarter)
2.21M0.27M0.48M0.61M2.22M2.84M2.29M2.33M0.60M2.00M0.86M1.47M0.80M0.04M0.30M1.58M1.30M5.46M6.40M7.41M
Current Assets (Quarter)
104.13M90.79M77.46M61.26M53.85M50.71M68.09M60.37M52.01M43.79M33.27M23.86M15.65M34.80M5.99M154.23M134.56M236.66M195.56M179.01M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.43M0.37M0.35M0.33M0.29M0.24M0.20M0.17M0.13M0.19M0.78M0.85M0.93M0.88M
Other Non-Current Assets (Quarter)
1.56M0.05M0.05M2.22M0.81M0.29M0.05M0.05M0.05M0.60M0.19M0.14M0.05M0.81M0.11M1.25M1.22M1.16M1.50M
Non-Current Assets (Quarter)
3.81M3.56M4.00M3.78M2.11M1.10M0.84M1.45M1.19M1.53M0.94M0.56M0.05M0.81M3.21M3.71M3.64M3.57M3.75M
Assets (Quarter)
107.94M94.35M81.46M65.04M55.96M51.81M68.92M61.82M53.20M45.32M34.20M24.42M15.70M35.62M5.99M157.43M138.27M240.29M199.13M182.76M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.39M2.11M2.28M1.27M0.85M0.97M0.48M0.24M0.33M0.87M0.76M0.95M0.58M0.11M0.10M1.65M2.56M10.00M1.19M2.54M
Payables (Quarter)
1.39M2.11M2.28M1.27M0.85M0.97M0.48M0.24M0.33M0.87M0.76M0.95M0.58M0.11M0.10M1.65M2.56M10.00M1.19M2.54M
Accumulated Expenses (Quarter)
7.30M8.72M9.48M0.47M1.74M0.30M1.10M5.51M1.72M5.23M0.57M0.55M0.44M2.23M2.51M7.61M8.96M16.34M4.43M7.41M
Other Accumulated Expenses (Quarter)
0.16M0.09M0.11M0.08M0.06M0.04M0.06M0.02M0.02M0.01M0.05M
Current Leases (Quarter)
0.97M1.00M1.03M1.06M1.08M0.92M0.65M0.82M0.75M0.74M0.63M0.45M0.26M0.20M0.42M0.43M0.50M0.50M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
4.16M3.12M3.12M
Total Current Liabilities (Quarter)
9.66M11.82M12.78M8.94M7.75M8.88M6.74M6.57M6.39M6.84M5.29M4.36M4.32M9.61M2.62M16.75M20.30M36.07M14.19M18.54M
Non-Current Liabilities
Non-Current Debt (Quarter)
37.48M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
4.00M4.00M4.00M
Operating Leases (Quarter)
1.18M0.92M0.65M0.38M0.10M0.45M0.26M0.07M1.40M1.30M1.21M1.54M1.44M
Other Non-Current Liabilities (Quarter)
0.54M
Total Non-Current Liabilities (Quarter)
10.84M12.74M13.43M9.32M7.84M8.88M6.74M7.02M6.65M6.90M5.29M4.36M4.32M47.10M
Total Liabilities (Quarter)
11.38M12.74M13.43M9.32M7.84M8.88M6.74M7.02M6.65M6.90M5.29M4.36M4.32M47.10M2.62M18.18M21.63M37.28M15.28M19.50M
Shareholder's Equity
Total Debt (Quarter)
37.48M
Common Equity (Quarter)
96.57M81.60M68.03M55.73M48.12M42.93M62.18M54.80M46.55M38.41M28.91M20.06M-1.30M-15.48M-30.16M139.25M116.64M203.01M183.85M163.25M
Liabilities and Shareholders Equity (Quarter)
107.94M94.35M81.46M65.04M55.96M51.81M68.92M61.82M53.20M45.32M34.20M24.42M15.70M35.62M5.99M157.43M138.27M240.29M199.13M182.76M
Retained Earnings (Quarter)
-355.48M-372.90M455.53M456.49M-409.34M462.46M-429.90M-438.20M-447.40M-456.49M-467.22M-477.32M-487.14M2.39M500.02M-54.80M192.04M370.79M-195.09M379.16M
Preferred Shares (Quarter)
4.00M4.00M4.00M4.00M4.00M
Treasury Shares (Quarter)
0.40M0.35M0.27M0.22M0.21M0.20M0.12M0.12M0.12M0.12M0.06M0.05M20.00M20.00M20.00M0.44M0.74M0.61M0.56M